Filing Flows › Celularity (CELU) › Q1 2025
Celularity (CELU) Q1 2025 earnings results (first quarter 2025)
10-Q filed Aug 29, 2025
Celularity (CELU) reported revenue of $11.4M for the first quarter 2025 (Q1 2025), -22% from a year earlier and -37% from the quarter before. Operating margin was -91.8%, net loss $19.8M (172.9% of revenue).
Celularity, Q1 2025: revenue $11.4M (-22% year over year), operating margin -91.8%, net loss $19.8M, operating cash flow −$3.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.4M | -37% | -22% |
| Operating profit | −$10.5M | — | — |
| Net earnings | −$19.8M | — | — |
| Operating cash flow | −$3.0M | -288% | — |
What changed
Revenue was $11.4M in Q1 2025, down 22% year over year and down 37% from the previous quarter. Product was the largest line at 79% of revenue. Product lost $3.8M year over year (down 30%), 118% of the total change.
Operating costs exceeded revenue by $10.5M, an operating margin of -91.8%. Total costs fell 1% while revenue fell 22%. The fastest-growing cost line was Cost of revenue (+117%). The quarter ended with a net loss of $19.8M, wider than the previous quarter's $13.3M loss.
Operating cash flow was −$3.0M. Non-cash charges added back $1.8M of depreciation and amortization and $2.6M of share-based compensation. Working capital and other items added $12.3M.
Questions
What was Celularity's revenue in the first quarter 2025?
Celularity (CELU) reported revenue of $11.4M for the first quarter 2025 (Q1 2025), -22% from a year earlier and -37% from the quarter before.
Was Celularity profitable in the first quarter 2025?
Operating loss was $10.5M (-91.8% of revenue) and net loss $19.8M.
Source: Celularity 10-Q on SEC EDGAR.